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I.  General Information 
 
The following reagents were purchased and used as received: toluene (Sigma-
Aldrich; anhydrous in a Sure-Seal bottle), diethyl malonate (Alfa), and 2-methoxyphenol 
(Sigma-Aldrich).  Diallyl malonate1 and phosphepine 12 were synthesized according to 
literature procedures.  HPLC analyses were carried out on an Agilent 1100 Series 
system with Daicel Chiralpak® columns in hexane/isopropanol mixtures. 
 
 
II.  Preparation of Allenes 
 
General Procedure A: Preparation of Allenes.  A 250-mL flask was charged with 
the olefinating agent (ethyl (triphenylphosphoranylidene)acetate, benzyl 
                                                
(1) Imao D, Itoi A, Yamazaki A, Shirakura M, Ohtoshi R, Ogata K, Ohmori Y, Ohta T, 
Ito Y (2007) Easy access to esters with a benzylic quaternary carbon center from 
diallyl malonates by palladium-catalyzed decarboxylative allylation. J Org Chem 
72:1652–1658. 
(2) Junge K, Hagemann B, Enthaler S, Spannenberg A, Michalik M, Oehme G, 
Monsees A, Riermeier T, Beller M (2004) Synthesis of chiral monodentate 
binaphthophosphepine ligands and their application in asymmetric 
hydrogenations. Tetrahedron: Asymmetry 15:2621–2631. 
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(triphenylphosphoranylidene)acetate, or N-methoxy-N-
methyl(triphenylphosphoranylidene)acetamide) (20.0 mmol), evacuated, and backfilled 
with argon.  CH2Cl2 (100 mL) and Et3N (2.50 mL, 18.0 mmol) were added via syringe, 
and the solution was cooled to –78 °C.  The acid chloride (20.0 mmol) was then added 
dropwise via syringe over 10 min.  The solution was allowed to warm to room 
temperature over 3-4 h.  Then, the reaction mixture was concentrated to one-third of the 
original volume, and pentane (100 mL) was added.  The mixture was stirred for 1 h, and 
then it was passed through a pad of celite.  The filtrate was concentrated on a rotary 
evaporator, and the residue was purified by flash chromatography (hexanes/Et2O), 
which furnished the allene as an oil. 
The synthesis of the allenoates depicted in entries 2, 3, 5, and 6 of Table 2 has been 
described previously.3 
The yields have not been optimized. 
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(±)-Ethyl penta-2,3-dienoate.  The compound was prepared from propionyl chloride 
according to General Procedure A (purification by flash chromatography: 10% Et2O in 
pentane; 50% yield). 
1H NMR (CDCl3, 400 MHz) δ 5.61-5.51 (m, 2H), 4.18 (q, J = 7.2 Hz, 2H), 1.77 (dd, J = 
3.2 Hz, J = 7.2 Hz, 3H), 1.26 (t, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 212.9, 166.2, 90.2, 87.7, 60.7, 14.2, 12.8. 
IR (film) 2983, 2932, 1962, 1721, 1445, 1413, 1253, 1161 cm-1. 
LRMS (ES+) calcd for C7H10O2 (M+) 126.1, found 126.9. 
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(±)-Ethyl 8-(triisopropylsilyloxy)octa-2,3-dienoate.  The compound was prepared 
from 6-(triisopropylsilyloxy)hexanoyl chloride according to General Procedure A 
(purification by flash chromatography: 10% Et2O in hexanes; 65% yield). 
1H NMR (CDCl3, 400 MHz) δ 5.64-5.56 (m, 2H), 4.18 (dq, J = 1.6 Hz, J = 7.2 Hz, 2H), 
3.69 (t, J = 6.4 Hz, 2H), 2.20-2.14 (m, 2H), 1.64-1.52 (m, 4H), 1.28 (t, J = 7.2 Hz, 3H), 1.13-
1.02 (m, 21H). 
13C NMR (CDCl3, 100 MHz) δ 212.6, 166.4, 95.4, 88.6, 63.0, 61.0, 32.2, 27.3, 25.1, 18.0, 
14.6, 12.0. 
IR (film) 2942, 2866, 1962, 1721, 1464, 1255, 1159, 1108 cm-1. 
                                                
(3) Sun J, Fu GC (2010) Phosphine-catalyzed formation of carbon–sulfur bonds: 
Catalytic asymmetric synthesis of γ-thioesters. J Am Chem Soc 132:4568–4569. 
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LRMS (ES+) calcd for C19H37O3Si (M+H+) 341.3, found 341.9. 
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(±)-1-Ethyl 8-methyl octa-2,3-dienedioate.  The compound was prepared from 
methyl 6-chloro-6-oxohexanoate according to General Procedure A (purification by 
flash chromatography: 10% Et2O in hexanes; 75% yield). 
1H NMR (CDCl3, 400 MHz) δ 5.57-5.54 (m, 2H), 4.17-4.12 (m, 2H), 3.62 (s, 3H), 2.36 
(dt, J = 2.0 Hz, J = 7.2 Hz, 2H), 2.18-2.12 (m, 2H), 1.80-1.74 (m, 2H), 1.24 (t, J = 7.2 Hz, 
3H). 
13C NMR (CDCl3, 100 MHz) δ 212.2, 173.6, 165.9, 94.3, 88.6, 60.7, 51.4, 32.8, 26.7, 23.6, 
14.1. 
IR (film) 2983, 2953, 1961, 1717, 1438, 1420, 1254 cm-1. 
LRMS (ES+) calcd for C11H16O4 (M+) 212.1, found 212.9. 
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(± )-(Z)-Ethyl icosa-2,3,11-trienoate.  The compound was prepared from (Z)-9-
octadecenoyl chloride according to General Procedure A (purification by flash 
chromatography: 10% Et2O in hexanes; 71% yield). 
1H NMR (CDCl3, 400 MHz) δ 5.63-5.55 (m, 2H), 5.38-5.31 (m, 2H), 4.18 (q, J = 7.2 Hz, 
2H), 2.16-2.09 (m, 2H), 2.04-1.99 (m, 4H), 1.47-1.26 (m, 23H), 0.87 (t, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 212.3, 166.3, 130.0, 129.7, 95.3, 88.2, 60.7, 31.9, 29.8, 
29.6, 29.5, 29.3 (2), 29.0, 28.8, 28.7, 27.5, 27.2, 27.1, 22.7, 14.2, 14.1. 
IR (film) 2927, 2855, 1962, 1720, 1465, 1252, 1157 cm-1. 
LRMS (ES+) calcd for C22H39O2 (M+H+) 335.3, found 335.3. 
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(±)-Benzyl hepta-2,3-dienoate.  The compound was prepared from valeryl chloride 
according to General Procedure A (purification by flash chromatography: 10% Et2O in 
hexanes; 67% yield). 
1H NMR (CDCl3, 400 MHz) δ 7.37-7.31 (m, 5H), 5.64-5.61 (m, 2H), 5.21 (d, J = 12.4 Hz, 
1H), 5.16 (d, J = 12.4 Hz, 1H), 2.15-2.09 (m, 2H), 1.53-1.44 (m, 2H), 0.94 (t, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 212.7, 166.1, 136.0, 128.5, 128.11, 128.07, 95.3, 88.0, 66.4, 
29.5, 22.0, 13.5. 
IR (film) 3034, 2961, 2934, 2874, 1960, 1722, 1498, 1456, 1260, 1152 cm-1. 
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LRMS (ES+) calcd for C14H17O2 (M+H+) 217.1, found 217.8. 
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(±)-Benzyl trideca-2,3,12-trienoate.  The compound was prepared from undec-10-
enoyl chloride according to General Procedure A (purification by flash 
chromatography: 10% Et2O in hexanes; 75% yield). 
1H NMR (CDCl3, 400 MHz) δ 7.37-7.32 (m, 5H), 5.86-5.76 (m, 1H), 5.66-5.62 (m, 2H), 
5.20 (d, J = 12.8 Hz, 1H), 5.16 (d, J = 12.8 Hz, 1H), 5.02-4.92 (m, 2H), 2.16-2.10 (m, 2H), 
2.06-2.01 (m, 2H), 1.49-1.27 (m, 10H). 
13C NMR (CDCl3, 100 MHz) δ 212.6, 166.1, 139.1, 136.0, 128.5, 128.1, 128.0, 114.2, 95.6, 
88.0, 66.4, 33.8, 29.2, 29.0, 28.9, 28.7, 27.4. 
IR (film) 3068, 3034, 2928, 2855, 1960, 1723, 1456, 1257, 1150 cm-1. 
LRMS (ES+) calcd for C20H26O2 (M+) 298.2, found 298.9. 
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(±)-Benzyl 5-methoxypenta-2,3-dienoate.  The compound was prepared from 3-
methoxypropanoyl chloride according to General Procedure A (purification by flash 
chromatography: 15% Et2O in hexanes; 60% yield). 
1H NMR (CDCl3, 400 MHz) δ 7.34-7.28 (m, 5H), 5.74-5.64 (m, 2H), 5.18 (d, J = 12.4 Hz, 
1H), 5.14 (d, J = 12.8 Hz, 1H), 4.11-3.99 (m, 2H), 3.30 (s, 3H). 
13C NMR (CDCl3, 100 MHz) δ 212.6, 165.3, 135.7, 128.5, 128.23, 128.18, 92.9, 89.0, 68.5, 
66.7, 57.8. 
IR (film) 3066, 3034, 2989, 1963, 1717, 1456, 1260, 1153 cm-1. 
LRMS (ES+) calcd for C13H15O3 (M+H+) 219.1, found 219.9. 
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(±)-Benzyl 5-cyclopentylpenta-2,3-dienoate.  The compound was prepared from 3-
cyclopentylpropanoyl chloride according to General Procedure A (purification by flash 
chromatography: 10% Et2O in hexanes; 75% yield). 
1H NMR (CDCl3, 400 MHz) δ 7.36-7.26 (m, 5H), 5.63-5.58 (m, 2H), 5.21 (d, J = 12.0 Hz, 
1H), 5.16 (d, J = 12.8 Hz, 1H), 2.16-2.12 (m, 2H), 1.97-1.90 (m, 1H), 1.80-1.73 (m, 2H), 
1.63-1.44 (m, 4H), 1.20-1.12 (m, 2H). 
13C NMR (CDCl3, 100 MHz) δ 212.9, 166.1, 136.0, 128.5, 128.2, 128.1, 94.8, 87.6, 66.4, 
39.4, 33.9, 32.3, 25.22, 25.20. 
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IR (film) 3066, 3034, 2950, 2867, 1960, 1722, 1498, 1257, 1149 cm-1. 
LRMS (ES+) calcd for C17H21O2 (M+H+) 257.2, found 257.8. 
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(±)-N-Methoxy-N-methylpenta-2,3-dienamide.  The compound was prepared from 
propionyl chloride according to General Procedure A (purification by flash 
chromatography: 50% EtOAc in hexanes; 50% yield). 
1H NMR (CDCl3, 400 MHz) δ 6.12-6.10 (m, 1H), 5.62-5.58 (m, 1H), 3.70 (s, 3H), 3.22 (s, 
3H), 1.77 (dd, J = 3.2 Hz, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 212.6, 165.9, 90.1, 85.7, 61.6, 32.5, 12.9. 
IR (film) 2975, 2937, 1961, 1654, 1422, 1356, 1179 cm-1. 
LRMS (ES+) calcd for C7H11NO2 (M+) 141.1, found 141.9. 
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(±)-N-Methoxy-N-methylhepta-2,3-dienamide.  The compound was prepared from 
valeryl chloride according to General Procedure A [purification by flash 
chromatography: 1/1 mixture of CH2Cl2 and (20%→50% EtOAc in hexanes); 55% yield). 
1H NMR (CDCl3, 400 MHz) δ 6.15-6.12 (m, 1H), 5.64-5.59 (m, 1H), 3.69 (s, 3H), 3.21 (s, 
3H), 2.13-2.06 (m, 2H), 1.52-1.42 (m, 2H), 0.93 (t, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 212.1, 166.0, 95.1, 86.1, 61.6, 32.5, 29.6, 22.1, 13.5. 
IR (film) 2962, 2874, 1959, 1653, 1425, 1365, 1178 cm-1. 
LRMS (ES+) calcd for C9H16NO2 (M+H+) 170.1, found 170.0. 
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(±)-N-Methoxy-N-methyl-6-phenylhexa-2,3-dienamide.  The compound was 
prepared from 4-phenylbutanoyl chloride according to General Procedure A 
(purification by flash chromatography: 50% EtOAc in hexanes; 45% yield). 
1H NMR (CDCl3, 400 MHz) δ 7.27-7.23 (m, 2H), 7.18-7.14 (m, 3H), 6.15-6.12 (m, 1H), 
5.69-5.64 (m, 1H), 3.67 (s, 3H), 3.21 (s, 3H), 2.77-2.73 (m, 2H), 2.45-2.39 (m, 2H). 
13C NMR (CDCl3, 100 MHz) δ 212.0, 165.9, 141.2, 128.4, 128.3, 126.0, 94.8, 86.7, 61.6, 
35.1, 32.6, 29.2. 
IR (film) 3027, 2936, 2858, 1959, 1652, 1496, 1425, 1364, 1178 cm-1. 
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LRMS (ES+) calcd for C14H17NO2 (M+) 231.1, found 231.9. 
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N-Methoxy-N-methylocta-2,3-dien-7-ynamide.  The compound was prepared from 
hex-5-ynoyl chloride according to General Procedure A (purification by flash 
chromatography: 1/1 mixture of CH2Cl2 and (20%→50% EtOAc in hexanes); 40% yield). 
1H NMR (CDCl3, 400 MHz) δ 6.23-6.20 (m, 1H), 5.76-5.71 (m, 1H), 3.71 (s, 3H), 3.24 (s, 
3H), 2.41-2.32 (m, 4H), 1.99 (t, J = 2.4 Hz, 1H). 
13C NMR (CDCl3, 100 MHz) δ 211.8, 165.6, 93.9, 87.2, 83.1, 69.1, 61.7, 32.6, 26.7, 18.1. 
IR (film) 3295, 3243, 2966, 2937, 1962, 1651, 1430, 1367, 1180, 996 cm-1. 
LRMS (ES+) calcd for C10H13NO2 (M+) 179.1, found 179.9. 
 
 
III.  Phosphine-Catalyzed Enantioselective γ Additions 
 
General Procedure B.  An oven-dried 4-mL vial was charged with (S)-1 (19.5 mg, 
0.050 mmol), anhydrous toluene (0.3 mL), 2-methoxyphenol (5.5 µL, 0.050 mmol), and 
the 1,3-dicarbonyl compound (0.55 mmol).  The vial was capped, purged with nitrogen 
for 1 min, and cooled to –30 °C.  Next, the allene (0.50 mmol) was added via syringe 
over 2 min.  The cap was then sealed with grease, and the mixture was stirred at –30 °C 
for 48 h.  Next, hydrogen peroxide (30% in H2O; 0.2 mL) was added dropwise, and the 
mixture was stirred for 30 min.  The reaction mixture was then warmed to 0 °C, and a 
saturated aqueous solution of Na2SO3 (2 mL) was added dropwise.  The aqueous layer 
was extracted with Et2O (3 mL × 3; EtOAc for Weinreb amides), and the combined 
organic layers were dried over Na2SO4 and filtered.  The solvent was removed on a 
rotary evaporator, and the product was purified by flash chromatography. 
Notes: 1) A gram-scale reaction was conducted for entry 7 of Table 2 (see below).  2) 
Phosphepine 1 is relatively stable to oxidation: after exposure to air for two weeks, only 
a trace of the phosphine oxide was observed by 31P NMR spectroscopy.  3) The course 
of the reaction is concentration-dependent. 
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(E)-1,1-Diallyl 4-ethyl 2-methylbut-3-ene-1,1,4-tricarboxylate (Table 2, entry 1).  
The compound was prepared according to General Procedure B from (±)-ethyl penta-
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2,3-dienoate (64 mg, 0.50 mmol) and diallyl malonate (94 µL, 0.55 mmol).  After 
purification by flash chromatography (2.5→20% EtOAc in hexanes), the title compound 
was isolated as a colorless oil (144 mg, 93% yield) with 94% ee. 
[α]D22 = –15 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK IC-
H column; 5.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 10.8 min (major), 19.1 
min (minor). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (147 mg, 95% yield) with 94% ee. 
1H NMR (CDCl3, 400 MHz) δ 6.86 (dd, J = 8.0 Hz, J = 15.6 Hz, 1H), 5.92-5.82 (m, 3H), 
5.35-5.21 (m, 4H), 4.65 (t, J = 1.6 Hz, 1H), 4.63 (t, J = 1.2 Hz, 1H), 4.61 (t, J = 1.6 Hz, 1H), 
4.59 (t, J = 1.6 Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 3.42 (d, J = 8.8 Hz, 1H), 3.16-3.10 (m, 1H), 
1.27 (t, J = 7.2 Hz, 3H), 1.16 (d, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 167.30, 167.25, 166.2, 148.7, 131.3, 122.2, 119.01, 118.96, 
66.12, 66.09, 60.4, 56.7, 36.3, 17.3, 14.2. 
IR (film) 3088, 2982, 1732, 1653, 1450, 1368, 1159 cm-1. 
LRMS (ES+) calcd for C16H23O6 (M+H+) 311.2, found 311.1. 
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(E)-1,1-Diallyl 4-ethyl 2-(but-3-yn-1-yl)but-3-ene-1,1,4-tricarboxylate (Table 2, 
entry 2).  The compound was prepared according to General Procedure B from (±)-
ethyl octa-2,3-dien-7-ynoate (82 mg, 0.50 mmol) and diallyl malonate (94 µL, 0.55 
mmol).  After purification by flash chromatography (5→20% EtOAc in hexanes), the 
title compound was isolated as a colorless oil (157 mg, 90% yield) with 91% ee. 
[α]D22 = +20 (c = 1.1, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK OD-
H column; 2.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 13.6 min (major), 20.0 
min (minor). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (150 mg, 86% yield) with 92% ee. 
1H NMR (CDCl3, 400 MHz) δ 6.75 (dd, J = 10.0 Hz, J = 15.6 Hz, 1H), 5.93 (dd, J = 16.0 
Hz, J = 0.6 Hz, 1H), 5.94-5.81 (m, 2H), 5.36-5.21 (m, 4H), 4.65-4.59 (m, 4H), 4.17 (q, J = 7.2 
Hz, 2H), 3.51 (d, J = 8.0 Hz, 1H), 3.18-3.10 (m, 1H), 2.28-2.20 (m, 1H), 2.15-2.08 (m, 1H), 
1.98 (t, J = 2.8 Hz, 1H), 1.83-1.78 (m, 1H), 1.69-1.60 (m, 1H), 1.28 (t, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 167.1, 167.0, 165.8, 145.8, 131.28, 131.26, 124.8, 119.1, 
82.6, 69.5, 66.24, 66.17, 60.5, 55.6, 41.0, 30.4, 16.3, 14.2. 
IR (film) 3296, 3087, 2984, 2941, 1734, 1653, 1448, 1370, 1159 cm-1. 
LRMS (ES+) calcd for C19H25O6 (M+H+) 349.2, found 349.1. 
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(E)-1,1-Diallyl 4-ethyl 2-(3-chloropropyl)but-3-ene-1,1,4-tricarboxylate (Table 2, 
entry 3).  The compound was prepared according to General Procedure B from (±)-
ethyl 7-chlorohepta-2,3-dienoate (94 mg, 0.50 mmol) and diallyl malonate (94 µL, 0.55 
mmol).  After purification by flash chromatography (5→20% EtOAc in hexanes), the 
title compound was isolated as a colorless oil (169 mg, 91% yield) with 93% ee. 
[α]D22 = –0.92 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK 
AD-H column; 5.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 11.9 min (minor), 
13.1 min (major). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (167 mg, 90% yield) with 93% ee. 
1H NMR (CDCl3, 400 MHz) δ 6.75 (dd, J = 10.0 Hz, J = 15.6 Hz, 1H), 5.93-5.80 (m, 3H), 
5.35-5.21 (m, 4H), 4.65 (t, J = 1.6 Hz, 1H), 4.63 (t, J = 1.2 Hz, 1H), 4.60 (t, J = 1.6 Hz, 1H), 
4.58 (t, J = 1.2 Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 3.52-3.46 (m, 3H), 2.96 (qd, J = 8.8 Hz, J = 
2.4 Hz, 1H), 1.82-1.65 (m, 3H), 1.59-1.52 (m, 1H), 1.28 (t, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 167.1, 167.0, 165.7, 146.5, 131.3, 131.2, 124.4, 119.2, 
119.1, 66.3, 66.2, 60.5, 55.9, 44.3, 41.7, 30.1, 29.2, 14.2. 
IR (film) 3088, 2984, 2958, 2874, 1733, 1654, 1448, 1369, 1158 cm-1. 
LRMS (ES+) calcd for C18H26ClO6 (M+H+) 373.1, found 373.7. 
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(E)-1,1-Diallyl 4-ethyl 2-(4-(triisopropylsilyloxy)butyl)but-3-ene-1,1,4-
tricarboxylate (Table 2, entry 4).  The compound was prepared according to General 
Procedure B from (±)-ethyl 8-(triisopropylsilyloxy)octa-2,3-dienoate (170 mg, 0.50 
mmol) and diallyl malonate (94 µL, 0.55 mmol).  After purification by flash 
chromatography (5→20% EtOAc in hexanes), the title compound was isolated as a 
colorless oil (197 mg, 75% yield) with 88% ee. 
[α]D22 = +1.2 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK IC-
H column; 2.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 18.0 min (minor), 20.5 
min (major). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (210 mg, 80% yield) with 86% ee. 
1H NMR (CDCl3, 400 MHz) δ 6.76 (dd, J = 9.6 Hz, J = 15.6 Hz, 1H), 5.93-5.80 (m, 3H), 
5.34-5.20 (m, 4H), 4.64 (t, J = 1.6 Hz, 1H), 4.62 (t, J = 1.2 Hz, 1H), 4.59 (t, J = 1.6 Hz, 1H), 
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4.57 (t, J = 1.2 Hz, 1H), 4.16 (q, J = 6.8 Hz, 2H), 3.63 (t, J = 6.4 Hz, 2H), 3.47 (d, J = 8.4 Hz, 
1H), 2.99-2.91 (m, 1H), 1.59-1.23 (m, 6H), 1.27 (t, J = 7.2 Hz, 3H), 1.10-0.99 (m, 21H). 
13C NMR (CDCl3, 100 MHz) δ 167.4, 167.2, 165.9, 147.2, 131.4, 131.3, 123.9, 119.0, 
118.9, 66.1, 66.0, 63.0, 60.3, 56.0, 42.3, 32.6, 31.7, 23.4, 18.0, 14.2, 11.9. 
IR (film) 3088, 2942, 2866, 1737, 1652, 1463, 1368, 1158 cm-1. 
LRMS (ES+) calcd for C28H49O7Si (M+H+) 525.3, found 525.3. 
 
 
EtO
O
O
O O
O
OBn
 
(E)-1,1-Diallyl 4-ethyl 2-(4-(benzyloxy)butyl)but-3-ene-1,1,4-tricarboxylate (Table 
2, entry 5).  The compound was prepared according to General Procedure B from (±)-
ethyl 8-(benzyloxy)octa-2,3-dienoate (137 mg, 0.50 mmol) and diallyl malonate (94 µL, 
0.55 mmol).  After purification by flash chromatography (5→20% EtOAc in hexanes), 
the title compound was isolated as a colorless oil (183 mg, 80% yield) with 90% ee. 
[α]D22 = +1.2 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK AS-
H column; 3.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 13.9 min (minor), 15.0 
min (major). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (174 mg, 76% yield) with 90% ee. 
1H NMR (CDCl3, 400 MHz) δ 7.35-7.25 (m, 5H), 6.77 (dd, J = 8.8 Hz, J = 15.6 Hz, 1H), 
5.92-5.80 (m, 3H), 5.34-5.20 (m, 4H), 4.63-4.57 (m, 4H), 4.47 (s, 2H), 4.17 (q, J = 7.2 Hz, 
2H), 3.47 (d, J = 8.8 Hz, 1H), 3.42 (t, J = 6.4 Hz, 2H), 2.99-2.91 (m, 1H), 1.65-1.22 (m, 6H), 
1.27 (t, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 167.3, 167.1, 165.9, 147.2, 138.4, 131.29, 131.26, 128.3, 
127.5, 127.4, 123.9, 118.94, 118.91, 72.8, 69.8, 66.1, 66.0, 60.3, 55.9, 42.2, 31.7, 29.3, 23.7, 
14.2. 
IR (film) 2938, 2860, 1733, 1650, 1454, 1368, 1158 cm-1. 
LRMS (ES+) calcd for C26H35O7 (M+H+) 459.2, found 459.2. 
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(E)-1,1-Diallyl 4-ethyl 2-(2-(2-phenyl-1,3-dioxolan-2-yl)ethyl)but-3-ene-1,1,4-
tricarboxylate (Table 2, entry 6).  The compound was prepared according to General 
Procedure B from (±)-ethyl 6-(2-phenyl-1,3-dioxolan-2-yl)hexa-2,3-dienoate (144 mg, 
  S–10 
0.50 mmol) and diallyl malonate (94 µL, 0.55 mmol).  After purification by flash 
chromatography (5→20% EtOAc in hexanes), the title compound was isolated as a 
colorless oil (177 mg, 72% yield) with 94% ee. 
[α]D22 = +0.23 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK 
IA-H column; 3.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 15.7 min (minor), 
16.9 min (major). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (165 mg, 70% yield) with 94% ee. 
1H NMR (CDCl3, 400 MHz) δ 7.41-7.38 (m, 2H), 7.35-7.27 (m, 3H), 6.73 (dd, J = 9.6 
Hz, J = 15.6 Hz, 1H), 5.89-5.78 (m, 3H), 5.33-5.18 (m, 4H), 4.60-4.55 (m, 4H), 4.15 (q, J = 
7.2 Hz, 2H), 4.00-3.93 (m, 2H), 3.78-3.71 (m, 2H), 3.46 (d, J = 6.8 Hz, 1H), 3.01-2.90 (m, 
1H), 1.92-1.76 (m, 2H), 1.71-1.61 (m, 1H), 1.54-1.41 (m, 1H), 1.27 (t, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 167.3, 167.1, 165.9, 147.0, 142.3, 131.4, 128.1, 127.9, 
125.6, 124.2, 118.9, 109.8, 66.1, 66.0, 64.52, 64.46, 60.3, 56.0, 42.1, 37.7, 25.9, 14.2. 
IR (film) 2954, 2891, 1734, 1651, 1448, 1369, 1269, 1235, 1157 cm-1. 
LRMS (ES+) calcd for C26H33O8 (M+H+) 473.2, found 473.2. 
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(E)-1,1-Diallyl 5-methyl 2-(3-ethoxy-3-oxoprop-1-en-1-yl)pentane-1,1,5-
tricarboxylate (Table 2, entry 7).  The compound was prepared according to General 
Procedure B from (±)-1-ethyl 8-methyl octa-2,3-dienedioate (106 mg, 0.50 mmol) and 
diallyl malonate (94 µL, 0.55 mmol).  After purification by flash chromatography 
(5→20% EtOAc in hexanes), the title compound was isolated as a colorless oil (150 mg, 
76% yield) with 94% ee. 
A gram-scale reaction was carried out according to General Procedure B with (±)-1-
ethyl 8-methyl octa-2,3-dienedioate (1.0 g, 4.7 mmol) and diallyl malonate (0.89 mL, 5.2 
mmol).  After purification by flash chromatography (5→20% EtOAc in hexanes), the 
title compound was isolated as a colorless oil (1.39 g, 75% yield) with 94% ee. 
[α]D22 = –2.5 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK 
OD-H column; 2.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 24.2 min (major), 
34.9 min (minor). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (154 mg, 78% yield) with 94% ee. 
1H NMR (CDCl3, 600 MHz) δ 6.71 (dd, J = 9.6 Hz, J = 15.6 Hz, 1H), 5.87-5.77 (m, 3H), 
5.29-5.17 (m, 4H), 4.59 (d, J = 6.0 Hz, 2H), 4.54 (d, J = 5.4 Hz, 2H), 4.12 (q, J = 7.2 Hz, 2H), 
3.61 (s, 3H), 3.44 (d, J = 8.4 Hz, 1H), 2.93-2.89 (m, 1H), 2.29-2.19 (m, 2H), 1.61-1.33 (m, 
4H), 1.23 (t, J = 7.2 Hz, 3H). 
  S–11 
13C NMR (CDCl3, 100 MHz) δ 173.3, 167.1, 167.0, 165.7, 146.5, 131.18, 131.16, 124.2, 
118.94, 118.92, 66.1, 66.0, 60.3, 55.7, 51.4, 41.9, 33.4, 31.1, 22.3, 14.1. 
IR (film) 3087, 2953, 1735, 1653, 1438, 1369, 1157 cm-1. 
LRMS (ES+) calcd for C20H29O8 (M+H+) 397.2, found 397.2. 
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(E)-1,1-Diallyl 4-ethyl 2-((Z)-hexadec-7-en-1-yl)but-3-ene-1,1,4-tricarboxylate 
(Table 2, entry 8).  The compound was prepared according to General Procedure B 
from (± )-(Z)-ethyl icosa-2,3,11-trienoate (167 mg, 0.50 mmol) and diallyl malonate (94 
µL, 0.55 mmol).  After purification by flash chromatography (5→20% EtOAc in 
hexanes), the title compound was isolated as a colorless oil (174 mg, 67% yield) with 
87% ee. 
[α]D22 = –0.04 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK 
OD-H column; 1.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 5.8 min (major), 
9.3 min (minor). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (192 mg, 74% yield) with 85% ee. 
1H NMR (CDCl3, 400 MHz) δ 6.77 (dd, J = 8.8 Hz, J = 15.6 Hz, 1H), 5.94-5.80 (m, 3H), 
5.35-5.21 (m, 6H), 4.65 (t, J = 1.2 Hz, 1H), 4.63 (t, J = 1.4 Hz, 1H), 4.59 (t, J = 1.4 Hz, 1H), 
4.58 (t, J = 1.2 Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 3.48 (d, J = 8.8 Hz, 1H), 2.96-2.93 (m, 1H), 
2.00-1.99 (m, 4H), 1.55-1.14 (m, 25H), 0.87 (t, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 167.4, 167.2, 166.0, 147.5, 131.4, 131.3, 130.0, 129.7, 
123.8, 118.99, 118.96, 66.12, 66.05, 60.4, 56.0, 42.2, 31.92, 31.88, 29.74, 29.66, 29.5, 29.3, 29.2, 
29.1, 27.2, 27.1, 27.0, 22.7, 14.2, 14.1. 
IR (film) 3087, 2927, 2855, 1737, 1652, 1457, 1368, 1155 cm-1. 
LRMS (ES+) calcd for C31H51O6 (M+H+) 519.4, found 519.3. 
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(E)-4-Benzyl 1,1-diethyl 2-propylbut-3-ene-1,1,4-tricarboxylate (Table 2, entry 9).  
The compound was prepared according to General Procedure B from (±)-benzyl hepta-
2,3-dienoate (108 mg, 0.50 mmol) and diethyl malonate (84 µL, 0.55 mmol).  After 
purification by flash chromatography (2.5→20% Et2O in hexanes), the title compound 
was isolated as a colorless oil (156 mg, 83% yield) with 93% ee. 
  S–12 
[α]D22 = –4.5 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK IC-
H column; 5.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 17.8 min (minor), 19.5 
min (major). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (160 mg, 85% yield) with 93% ee. 
1H NMR (CDCl3, 400 MHz) δ 7.37-7.30 (m, 5H), 6.83 (dd, J = 9.6 Hz, J = 15.6 Hz, 1H), 
5.92 (d, J = 15.6 Hz, 1H), 5.16 (s, 2H), 4.20 (q, J = 7.2 Hz, 2H), 4.13 (q, J = 7.2 Hz, 2H), 3.39 
(d, J = 8.4 Hz, 1H), 3.00-2.92 (m, 1H), 1.52-1.21 (m, 4H), 1.26 (t, J = 7.2 Hz, 3H), 1.93 (t, J = 
7.2 Hz, 3H), 0.87 (t, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 167.8, 167.6, 165.8, 148.4, 135.9, 128.5, 128.18, 128.16, 
123.2, 66.2, 61.6, 61.4, 56.1, 42.0, 34.0, 20.2, 14.03, 13.98, 13.7. 
IR (film) 3034, 2961, 2936, 2874, 1728, 1656, 1456, 1370, 1156 cm-1. 
LRMS (ES+) calcd for C21H28O6 (M+) 376.2, found 376.8. 
 
 
BnO
O
EtO
O O
OEt
 
(E)-4-Benzyl 1,1-diethyl 2-(non-8-en-1-yl)but-3-ene-1,1,4-tricarboxylate (Table 2, 
entry 10).  The compound was prepared according to General Procedure B from (±)-
benzyl trideca-2,3,12-trienoate (149 mg, 0.50 mmol) and diethyl malonate (84 µL, 0.55 
mmol).  After purification by flash chromatography (2.5→20% EtOAc in hexanes), the 
title compound was isolated as a colorless oil (149 mg, 65% yield) with 90% ee. 
[α]D22 = +1.1 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK 
AD-H column; 2.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 16.8 min (major), 
18.0 min (minor). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (147 mg, 64% yield) with 90% ee. 
1H NMR (CDCl3, 400 MHz) δ 7.37-7.30 (m, 5H), 6.83 (dd, J = 8.4 Hz, J = 15.6 Hz, 1H), 
5.92 (dd, J = 0.8 Hz, J = 15.6 Hz, 1H), 5.85-5.74 (m, 1H), 5.17 (s, 2H), 5.01-4.90 (m, 2H), 
4.20 (q, J = 7.2 Hz, 2H), 4.13 (q, J = 7.2 Hz, 2H), 3.39 (d, J = 8.4 Hz, 1H), 2.98-2.90 (m, 1H), 
2.05-1.99 (m, 2H), 1.54-1.18 (m, 12H), 1.26 (t, J = 7.2 Hz, 3H), 1.19 (t, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 167.8, 167.4, 165.8, 148.5, 139.1, 135.9, 128.5, 128.2, 
123.2, 114.1, 66.2, 61.6, 61.4, 56.1, 42.2, 33.7, 31.9, 29.23, 29.19, 29.0, 28.8, 27.0, 14.1, 14.0. 
IR (film) 3067, 3034, 2980, 2928, 2856, 1752, 1731, 1656, 1456, 1370, 1305, 1154 cm-1. 
LRMS (ES+) calcd for C27H39O6 (M+H+) 459.3, found 459.3. 
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(E)-4-Benzyl 1,1-diethyl 2-(methoxymethyl)but-3-ene-1,1,4-tricarboxylate (Table 2, 
entry 11).  The compound was prepared according to General Procedure B from (±)-
benzyl 5-methoxypenta-2,3-dienoate (109 mg, 0.50 mmol) and diethyl malonate (84 µL, 
0.55 mmol).  After purification by flash chromatography (5→10% EtOAc in hexanes), 
the title compound was isolated as a colorless oil (138 mg, 73% yield) with 93% ee. 
[α]D22 = –20 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK OJ-
H column; 10.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 14.3 min (minor), 
15.7 min (major). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (142 mg, 75% yield) with 93% ee. 
1H NMR (CDCl3, 400 MHz) δ 7.36-7.30 (m, 5H), 6.97 (dd, J = 8.8 Hz, J = 15.6 Hz, 1H), 
5.97 (dd, J = 0.8 Hz, J = 15.6 Hz, 1H), 5.18 (d, J = 12.4 Hz, 1H), 5.14 (d, J = 12.4 Hz, 1H), 
4.19 (q, J = 7.2 Hz, 2H), 4.14 (q, J = 7.2 Hz, 2H), 3.64 (d, J = 8.0 Hz, 1H), 3.52-3.45 (m, 2H), 
3.29 (s, 3H), 3.27-3.21 (m, 1H), 1.25 (t, J = 7.2 Hz, 3H), 1.20 (t, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 167.8, 167.6, 165.7, 145.8, 135.9, 128.5, 128.2, 128.1, 
123.6, 72.5, 66.2, 61.6, 61.5, 58.9, 52.5, 41.9, 14.0, 13.9. 
IR (film) 3067, 3034, 2983, 2934, 1728, 1657, 1456, 1371, 1157, 1029 cm-1. 
LRMS (ES+) calcd for C20H27O7 (M+H+) 379.2, found 379.8. 
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(E)-4-Benzyl 1,1-diethyl 2-(cyclopentylmethyl)but-3-ene-1,1,4-tricarboxylate 
(Table 2, entry 12).  The compound was prepared according to General Procedure B, 
except that 15% of (S)-1 was used, from (±)-benzyl 5-cyclopentylpenta-2,3-dienoate (128 
mg, 0.50 mmol) and diethyl malonate (84 µL, 0.55 mmol).  After purification by flash 
chromatography (2→20% EtOAc in hexanes), the title compound was isolated as a 
colorless oil (146 mg, 70% yield) with 84% ee. 
[α]D22 = +16 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK IC-
H column; 5.0% i-PrOH in hexanes; 0.6 mL/min; retention times: 24.8 min (minor), 26.5 
min (major). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (148 mg, 71% yield) with 85% ee. 
  S–14 
1H NMR (CDCl3, 400 MHz) δ 7.37-7.31 (m, 5H), 6.84 (dd, J = 8.8 Hz, J = 15.6 Hz, 1H), 
5.93 (d, J = 15.6 Hz, 1H), 5.17 (s, 2H), 4.23-4.17 (m, 2H), 4.13 (q, J = 7.2 Hz, 2H), 3.37 (d, J 
= 8.4 Hz, 1H), 3.03-2.95 (m, 1H), 1.78-1.71 (m, 3H), 1.61-1.46 (m, 5H), 1.43-1.36 (m, 1H), 
1.26 (t, J = 7.2 Hz, 3H), 1.92 (t, J = 7.2 Hz, 3H), 1.17-1.03 (m, 2H). 
13C NMR (CDCl3, 100 MHz) δ 167.8, 167.7, 165.8, 148.6, 135.9, 128.5, 128.22, 128.19, 
123.1, 66.2, 61.6, 61.4, 56.4, 41.6, 38.4, 37.3, 33.3, 31.5, 25.1, 25.0, 14.1, 14.0. 
IR (film) 2950, 2869, 1731, 1656, 1455, 1370, 1303, 1150 cm-1. 
LRMS (ES+) calcd for C24H33O6 (M+H+) 417.2, found 417.8. 
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(E)-Diethyl 2-(5-(methoxy(methyl)amino)-5-oxopent-3-en-2-yl)malonate (Table 3, 
entry 1).  The compound was prepared according to General Procedure B from (±)-N-
methoxy-N-methylpenta-2,3-dienamide (71 mg, 0.50 mmol) and diethyl malonate (84 
µL, 0.55 mmol).  After purification by flash chromatography (3% MeOH in 1:1 
EtOAc/hexanes), the title compound was isolated as a colorless oil (99 mg, 66% yield) 
with 95% ee. 
[α]D22 = –9.6 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK 
AD-H column; 5.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 22.0 min (major), 
25.2 min (minor). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (114 mg, 76% yield) with 95% ee. 
1H NMR (CDCl3, 400 MHz) δ 6.83 (dd, J = 8.4 Hz, J = 15.6 Hz, 1H), 6.45 (d, J = 15.2 
Hz, 1H), 4.19 (q, J = 7.2 Hz, 2H), 4.13 (q, J = 7.2 Hz, 2H), 3.67 (s, 3H), 3.33 (d, J = 8.8 Hz, 
1H), 3.21 (s, 3H), 3.20-3.12 (m, 1H), 1.26 (t, J = 7.2 Hz, 3H), 1.22 (t, J = 7.2 Hz, 3H), 1.54 (d, 
J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 167.82, 167.76, 166.4, 147.4, 119.5, 61.7, 61.5, 61.4, 57.0, 
36.6, 32.3, 17.6, 14.03, 13.98. 
IR (film) 2980, 1732, 1666, 1636, 1465, 1371, 1177 cm-1. 
LRMS (ES+) calcd for C14H24NO6 (M+H+) 302.2, found 302.8. 
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(E)-Diethyl 2-(1-(methoxy(methyl)amino)-1-oxohept-2-en-4-yl)malonate (Table 3, 
entry 2).  The compound was prepared according to General Procedure B from (±)-N-
  S–15 
methoxy-N-methylhepta-2,3-dienamide (85 mg, 0.50 mmol) and diethyl malonate (84 
µL, 0.55 mmol).  After purification by flash chromatography (50→100% Et2O in 
hexanes), the title compound was isolated as a colorless oil (115 mg, 70% yield) with 
93% ee. 
[α]D22 = –0.86 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK 
AD-H column; 5.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 17.8 min (major), 
20.1 min (minor). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (102 mg, 62% yield) with 93% ee. 
1H NMR (CDCl3, 400 MHz) δ 6.72 (dd, J = 9.6 Hz, J = 15.2 Hz, 1H), 6.46 (d, J = 15.2 
Hz, 1H), 4.20 (q, J = 7.2 Hz, 2H), 4.12 (q, J = 7.2 Hz, 2H), 3.67 (s, 3H), 3.39 (d, J = 9.2 Hz, 
1H), 3.22 (s, 3H), 3.04-2.96 (m, 1H), 1.52-1.18 (m, 4H), 1.26 (t, J = 7.2 Hz, 3H), 1.21 (t, J = 
7.2 Hz, 3H), 0.86 (t, J = 7.2 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 168.0, 167.8, 166.2, 146.0, 121.2, 61.7, 61.5, 61.3, 56.4, 
42.3, 34.2, 32.3, 20.2, 14.1, 14.0, 13.7. 
IR (film) 2961, 2937, 2874, 1732, 1666, 1637, 1465, 1382, 1304, 1176 cm-1. 
LRMS (ES+) calcd for C16H28NO6 (M+H+) 330.2, found 330.8. 
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(E)-Diethyl 2-(6-(methoxy(methyl)amino)-6-oxo-1-phenylhex-4-en-3-yl)malonate 
(Table 3, entry 3).  The compound was prepared according to General Procedure B 
from (±)-N-methoxy-N-methyl-6-phenylhexa-2,3-dienamide (116 mg, 0.50 mmol) and 
diethyl malonate (84 µL, 0.55 mmol).  After purification by flash chromatography 
(25→50% EtOAc in hexanes), the title compound was isolated as a colorless oil (133 mg, 
68% yield) with 94% ee. 
[α]D22 = –2.1 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK IC-
H column; 20.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 32.6 min (major), 38.1 
min (minor). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (123 mg, 63% yield) with 95% ee. 
1H NMR (CDCl3, 400 MHz) δ 7.25-7.21 (m, 2H), 7.16-7.09 (m, 3H), 6.78 (dd, J = 10.0 
Hz, J = 15.6 Hz, 1H), 6.47 (d, J = 15.2 Hz, 1H), 4.18-4.06 (m, 4H), 3.66 (s, 3H), 3.40 (d, J = 
9.2 Hz, 1H), 3.21 (s, 3H), 3.05-3.00 (m, 1H), 2.66-2.60 (m, 1H), 2.51-2.43 (m, 1H), 1.88-1.81 
(m, 1H), 1.75-1.68 (m, 1H), 1.23-1.15 (m, 6H). 
13C NMR (CDCl3, 100 MHz) δ 167.7, 167.6, 166.1, 145.5, 141.2, 128.34, 128.31, 125.9, 
121.8, 61.7, 61.5, 61.4, 56.3, 42.1, 33.7, 33.2, 32.3, 14.00, 13.97. 
IR (film) 3063, 3026, 2981, 2937, 1750, 1732, 1665, 1635, 1496, 1302 cm-1. 
LRMS (ES+) calcd for C21H29NO6 (M+) 391.2, found 391.8. 
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(E)-Diethyl 2-(1-(methoxy(methyl)amino)-1-oxooct-2-en-7-yn-4-yl)malonate (Table 
3, entry 4).  The compound was prepared according to General Procedure B from (±)-N-
methoxy-N-methylocta-2,3-dien-7-ynamide (90 mg, 0.50 mmol) and diethyl malonate 
(84 µL, 0.55 mmol), except that the reaction time was 72 h.  After purification by flash 
chromatography (1:4:5→2:3:5 EtOAc:hexanes:CH2Cl2), the title compound was isolated 
as a colorless oil (120 mg, 71% yield) with 94% ee. 
[α]D22 = +42 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK AD-
H column; 5% i-PrOH in hexanes; 1.0 mL/min; retention times: 47.0 min (major), 53.8 
min (minor). 
The second run was performed with (R)-1.  The product was isolated as a colorless 
oil (115 mg, 68% yield) with 94% ee. 
1H NMR (CDCl3, 400 MHz) δ 6.69 (dd, J = 10.0 Hz, J = 15.6 Hz, 1H), 6.54 (d, J = 15.2 
Hz, 1H), 4.20 (dq, J = 2.0 Hz, J = 7.2 Hz, 2H), 4.13 (q, J = 7.2 Hz, 2H), 3.68 (s, 3H), 3.42 (d, 
J = 8.8 Hz, 1H), 3.22 (s, 3H), 3.22-3.14 (m, 1H), 2.26-2.19 (m, 1H), 2.14-2.03 (m, 1H), 1.96 
(t, J = 2.4 Hz, 1H), 1.83-1.75 (m, 1H), 1.68-1.59 (m, 1H), 1.26 (t, J = 7.2 Hz, 3H), 1.22 (t, J = 
7.2 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 167.6, 167.5, 165.9, 144.3, 122.3, 82.9, 69.2, 61.8, 61.6, 
61.5, 56.0, 41.3, 32.3, 30.4, 16.2, 14.04, 14.00. 
IR (film) 3286, 2959, 2925, 2854, 1732, 1664, 1635, 1464, 1378, 1032 cm-1. 
LRMS (ES+) calcd for C17H25NO6 (M+) 339.2, found 339.8. 
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10% 2-methoxyphenol
toluene, –30 °C
EtO
O
Me
O
EtO
• Me
racemic
Me OEt
O O
Me
O O
OEt
1.1 equiv
Me
Me
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2.5 (92% ee) : 1 (91% ee) dr  
(E)-Diethyl 5-acetyl-4,5-dimethylhex-2-enedioate (eq 4; relative and absolute 
stereochemistry to be determined).  The compound was prepared according to General 
Procedure B from (±)-ethyl penta-2,3-dienoate (126 mg, 1.0 mmol) and ethyl 2-methyl-
3-oxobutanoate (160 µL, 1.1 mmol), except that catalyst (R)-1 was used and the reaction 
was run for 72 h.  After purification by flash chromatography (20% EtOAc in hexanes), 
the title compounds were isolated as a colorless oil (194 mg, 72% yield (combined yield 
  S–17 
of a 2.5:1 mixture (1H NMR spectroscopy) of diastereomers); 92% (major) ee and 91% ee 
(minor)). 
Analytical data were obtained after HPLC separation of the diastereomers. 
Major diastereomer: 
[α]D22 = +5.0 (c = 1.0, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK 
OD-H column; 1.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 13.0 min (minor), 
27.5 min (major). 
1H NMR (CDCl3, 400 MHz) δ 6.82 (dd, J = 8.4 Hz, J = 15.6 Hz, 1H), 5.85 (dd, J = 1.2 
Hz, J = 16.0 Hz, 1H), 4.21 (q, J = 7.2 Hz, 2H), 4.17 (q, J = 7.2 Hz, 2H), 3.25-3.21 (m, 1H), 
2.14 (s, 3H), 1.31 (s, 3H), 1.28 (t, J = 7.2 Hz, 3H), 1.27 (t, J = 7.2 Hz, 3H), 1.06 (d, J = 6.8 Hz, 
3H). 
13C NMR (CDCl3, 100 MHz) δ 204.4, 171.2, 166.4, 148.3, 122.8, 62.9, 61.6, 60.4, 39.8, 
26.8, 15.9, 15.3, 14.2, 14.0. 
IR (film) 2982, 2941, 1716, 1652, 1449, 1367, 1235 cm-1. 
LRMS (ES+) calcd for C14H22O5 (M+) 270.2, found 270.9. 
Minor diastereomer: 
[α]D22 = +64 (c = 0.3, CHCl3).  HPLC analysis of the product: Daicel CHIRALPAK OD-
H column; 1.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 14.4 min (minor), 32.1 
min (major). 
1H NMR (CDCl3, 400 MHz) δ 6.90 (dd, J = 8.0 Hz, J = 15.6 Hz, 1H), 5.84 (dd, J = 1.2 
Hz, J = 15.6 Hz, 1H), 4.18 (q, J = 7.2 Hz, 2H), 4.17 (q, J = 7.2 Hz, 2H), 3.27-3.23 (m, 1H), 
2.16 (s, 3H), 1.31 (s, 3H), 1.28 (t, J = 7.2 Hz, 3H), 1.22 (t, J = 7.2 Hz, 3H), 1.01 (d, J = 7.2 Hz, 
3H). 
13C NMR (CDCl3, 100 MHz) δ 204.0, 171.3, 166.3, 148.7, 122.6, 63.0, 61.6, 60.3, 39.7, 
26.5, 15.2, 14.5, 14.2, 14.0. 
IR (film) 2981, 2923, 2851, 1716, 1652, 1449, 1261 cm-1. 
LRMS (ES+) calcd for C14H22O5 (M+) 270.2, found 270.9. 
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Kinetic resolution (eq 7).  An oven-dried 4-mL vial was charged with (S)-1 (19.5 mg, 
0.050 mmol), anhydrous toluene (0.3 mL), 2-methoxyphenol (5.5 µL, 0.050 mmol), 
  S–18 
diallyl malonate (94 µL, 0.55 mmol), and decane (49 µL, 0.25 mmol).  The vial was 
capped, purged with nitrogen for 1 min, and cooled to –30 °C.  Next, the allene (64 mg, 
0.50 mmol) was added via syringe over 2 min.  The cap was then sealed with grease, 
and the mixture was stirred at –30 °C.  Aliquots were removed, quenched with 
hydrogen peroxide (30% in H2O), and then extracted with Et2O (3 mL × 3).  The 
conversion of the reaction was determined by GC analysis; after 11 h, the conversion 
was 92%.  Hydrogen peroxide (30% in H2O; 0.4 mL) was added dropwise to the reaction 
mixture, and the resulting mixture was stirred for 30 min.  Next, the mixture was 
warmed to 0 oC, and a saturated aqueous solution of Na2SO3 (2 mL) was added 
dropwise.  The aqueous layer was extracted with Et2O (3 mL × 3), and the combined 
organic layers were dried over Na2SO4 and filtered.  GC analysis showed that the yields 
of product and starting allene were 90% and 8%, respectively.  The solvent was 
removed by rotary evaporation, and the product and the starting allene were purified 
by flash chromatography (2.5→10% Et2O in hexanes followed by 5→20% EtOAc in 
hexanes). 
HPLC analysis of the product showed 94% ee: Daicel CHIRALPAK IC-H column; 
5.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 10.8 min (major), 19.1 min 
(minor). 
The starting allene had a positive optical rotation, which corresponds to the (S) 
configuration.4  HPLC analysis showed 93% ee: Daicel CHIRALPAK AD-H column; 
1.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 14.8 min (major), 16.1 min 
(minor). 
 
 
IV.  Functionalization of the γ-Addition Products 
 
EtO
O
Me
O
OH
 
(R,E)-6-Ethoxy-3-methyl-6-oxohex-4-enoic acid (eq 5).  A flask was charged with a 
solution of (S,E)-1,1-diallyl 4-ethyl 2-methylbut-3-ene-1,1,4-tricarboxylate (product of 
Table 2, entry 1; 233 mg, 0.75 mmol), Pd(OAc)2 (16.8 mg, 0.075 mmol), PPh3 (39.3 mg, 
0.15 mmol), and Meldrum’s acid (0.55 g, 3.8 mmol) in 1,4-dioxane (7 mL).  The flask was 
purged with nitrogen, and the reaction mixture was refluxed for 3 h.  Next, the mixture 
was cooled to room temperature, the solvent was evaporated, and the residue was 
purified by flash chromatography (1:1 Et2O/hexanes→1:1:0.1 EtOAc/hexanes/MeOH), 
which afforded the title compound as a pale-yellow oil (115 mg, 82% yield). 
                                                
(4) Rossi R, Diversi P (1973) Synthesis, absolute configuration, and optical purity of 
chiral allenes. Synthesis 25–36. 
  S–19 
[α]D22 = +20 (c = 1.0, CHCl3).  HPLC analysis of the methyl ester of the product, 
which was prepared by methylation with TMSCH2N2: Daicel CHIRALPAK AD-H 
column; 2.0% i-PrOH in hexanes; 1.0 mL/min; retention times: 28.1 min (major), 29.9 
min (minor). 
1H NMR (CDCl3, 400 MHz) δ 10.4 (br s, 1H), 6.90 (dd, J = 7.2 Hz, J = 15.6 Hz, 1H), 
5.83 (dd, J = 1.2 Hz, J = 15.6 Hz, 1H), 4.18 (q, J = 7.2 Hz, 2H), 2.88-2.81 (m, 1H), 2.48 (dd, J 
= 7.2 Hz, J = 15.6 Hz, 1H), 2.37 (dd, J = 7.6 Hz, J = 16.0 Hz, 1H), 1.28 (t, J = 7.2 Hz, 3H), 
1.43 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 177.7, 166.6, 151.5, 120.5, 60.4, 40.0, 32.6, 19.0, 14.2. 
IR (film) 3200 (br), 2979, 1712, 1654, 1370, 1274, 1181, 1034 cm-1. 
LRMS (ES+) calcd for C9H14O4 (M+) 186.1, found 186.9. 
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Ethyl 2-((2S,3R)-3-methyl-5-oxotetrahydrofuran-2-yl)acetate (eq 6).  A flask was 
charged with a solution of (S,E)-1,1-diallyl 4-ethyl 2-methylbut-3-ene-1,1,4-
tricarboxylate (product of Table 2, entry 1; 142 mg, 0.46 mmol), Pd(OAc)2 (5.3 mg, 0.023 
mmol), PPh3 (24.5 mg, 0.094 mmol), formic acid (44 µL, 1.2 mmol), and Et3N (0.22 mL, 
1.5 mmol) in 1,4-dioxane (2.0 mL).  The flask was purged with nitrogen, and the 
reaction mixture was refluxed for 14 h.  Next, the reaction mixture was cooled to room 
temperature, poured into 1 N HCl (10 mL), and extracted with CH2Cl2 (10 mL × 3).  The 
combined organic layers were washed with brine, dried over MgSO4, filtered, and 
concentrated.  The residue was purified by flash chromatography (1:1 Et2O/hexanes), 
which furnished the title compound as a pale-yellow oil (72 mg, 85% yield (combined 
yield of a 7:1 mixture (1H NMR spectroscopy) of diastereomers); the cis stereochemistry 
of the major diastereomer was determined by nOe experiments)). 
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1H NMR (CDCl3, 400 MHz) δ 4.48-4.43 (m, 1H), 4.16 (q, J = 7.2 Hz, 2H), 2.72-2.64 (m, 
3H), 2.36-2.28 (m, 1H), 2.24-2.17 (m, 1H), 1.25 (t, J = 7.2 Hz, 3H), 1.16 (d, J = 6.8 Hz, 3H). 
13C NMR (CDCl3, 100 MHz) δ 175.6, 169.6, 82.6, 61.0, 38.7, 36.5, 35.6, 17.3, 14.1. 
  S–20 
IR (film) 2978, 2937, 1784, 1735, 1464, 1337, 1188, 1157 cm-1. 
LRMS (ES+) calcd for C9H14O4 (M+) 186.1, found 186.9. 
 
 
V.  Determination of the Absolute Configuration 
 
The absolute configuration of the product of entry 1 of Table 2 (from catalyst (S)-1) 
was determined. 
EtO
O
Me
O
O O
O
1) Pd/C, H2
2) KOH, MeOH, H2O
3) HCl, H2O, reflux
HO
O
Me
O
OH
 
 (S)-3-Methylhexanedioic acid.5  The product has [α]D22 = –12 (c = 1.2, CHCl3; 94% 
ee). 
 
 
The absolute configuration of the product of entry 1 of Table 3 (from catalyst (S)-1) 
was determined. 
N
O
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1) O3
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(S)-Diethyl 2-sec-butylmalonate.6  The product has [α]D22 = +7.8 (c = 2.0, CHCl3; 95% 
ee). 
 
 
The stereochemistry of the other products has been assigned by analogy. 
                                                
(5) Brown E, Deroye C, Touet J (1998) Synthesis of versatile chiral intermediates by 
enantioselective conjugate addition of alkenyl Grignard reagents to enamides 
deriving from (R)-(–)- or (S)-(+)-2-aminobutan-1-ol. Tetrahedron: Asymmetry 9:1605–
1614. 
(6) Schuppan J,  Minnaard AJ, Feringa BL (2004) A catalytic and iterative route to β-
substituted esters via highly enantioselective conjugate addition of dimethylzinc to 
unsaturated malonates. Chem Commun 792–793. 
 
 
































